全文获取类型
收费全文 | 1695篇 |
免费 | 94篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 31篇 |
妇产科学 | 92篇 |
基础医学 | 123篇 |
口腔科学 | 38篇 |
临床医学 | 157篇 |
内科学 | 378篇 |
皮肤病学 | 42篇 |
神经病学 | 120篇 |
特种医学 | 60篇 |
外国民族医学 | 1篇 |
外科学 | 276篇 |
综合类 | 39篇 |
预防医学 | 109篇 |
眼科学 | 73篇 |
药学 | 153篇 |
中国医学 | 7篇 |
肿瘤学 | 50篇 |
出版年
2024年 | 1篇 |
2023年 | 14篇 |
2022年 | 38篇 |
2021年 | 68篇 |
2020年 | 33篇 |
2019年 | 45篇 |
2018年 | 58篇 |
2017年 | 41篇 |
2016年 | 56篇 |
2015年 | 71篇 |
2014年 | 75篇 |
2013年 | 101篇 |
2012年 | 149篇 |
2011年 | 131篇 |
2010年 | 91篇 |
2009年 | 90篇 |
2008年 | 124篇 |
2007年 | 113篇 |
2006年 | 112篇 |
2005年 | 107篇 |
2004年 | 99篇 |
2003年 | 55篇 |
2002年 | 43篇 |
2001年 | 16篇 |
2000年 | 11篇 |
1999年 | 14篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 4篇 |
1994年 | 1篇 |
1992年 | 3篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1980年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1970年 | 2篇 |
1969年 | 1篇 |
1930年 | 1篇 |
排序方式: 共有1795条查询结果,搜索用时 15 毫秒
51.
Syed Qaiser Shah Gul‐e‐Raana Ghias Uddin 《Journal of labelled compounds & radiopharmaceuticals》2018,61(7):550-556
This investigation aimed to modify finasteride ( 1 ) to finasteride dithiocarbamate ( 2 ) for subsequent synthesis of the rhenium analogue ( 3 ) and [99mTc]tricarbonyl complexes ( 4 ), to assess its prostate cancer (PCa) targeting potential in a rat model. To validate the identity of ( 4) , reference ( 3) has been synthesized by using fac‐[Net4]2[ReBr3(CO)3] precursor and characterized by 1H‐NMR, 13C‐NMR, ESI‐MS, and elemental analysis. The analogue ( 4) was synthesized by using fac‐[99mTc(H2O)3(CO)3]+ precursor, and its structure was confirmed by comparative HPLC by using ( 3) as a reference. Further, the suitability of ( 4) as a PCa imaging agent was investigated in vitro and in vivo. At room temperature, ( 4) had ≥99% radiochemical purity and remained ≥84% stable in serum. In preclinical studies, biodistribution of ( 4) in histopathologically established rat model showed adequately high in vivo uptake in the prostate attracting the possibility of using it for noninvasive imaging of PCa. 相似文献
52.
53.
Coronary artery thromboembolism: Unexpected presentation of left atrial myxoma covered with thrombus
Samet Uysal MD Ayse Zehra Karakoc MD Kadir Biyikli MD Benay Erden MD Ozkan Candan MD Gonca Gul Gecmen MD 《Journal of cardiac surgery》2020,35(8):2097-2099
Cardiac myxomas are benign primer cardiac tumors of the heart. They can be fatal with a thromboembolic presentation. Myocardial infarction is one of these unusual thromboembolic presentations. We report a patient who presented with cardiac arrest due to ventricular fibrillation related to myocardial infarction. After successful resuscitation, coronary angiography and transthoracic echocardiography were performed. A left atrial mass was observed and interpreted as a possible cause of coronary embolism leading to myocardial infarction. After surgical excision, the pathological examination confirmed myxoma, which was the essential cause of the tendency to arterial embolism. 相似文献
54.
M. Saeed Arayne Najma Sultana Somia Gul Ajmal Khan 《Medicinal chemistry research》2014,23(3):1248-1256
Sparfloxacin (SPFX) or 5-amino-1-cyclopropyl-7-[(3R,5S)3,5-dimethylpiperazine-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid is an orally active synthetic, broad spectrum third generation quinolone, with excellent activity against Gram-positive bacteria with selectivity against anaerobes and atypical pathogens. Three derivatives of SPFX (2, 3, and 4) were synthesized by reacting different aromatic carboxylic acids with SPFX (1). Chemistry involved the formation of amide between reacting species through nucleophilic substitution reactions. The synthesized derivatives were then structurally characterized by IR, NMR, and mass spectroscopic techniques. The antimicrobial activities of these derivatives were evaluated against four Gram-positive, seven Gram-negative bacteria, and six fungi, using SPFX as a reference. Statistical analysis revealed these derivatives as active antimicrobial agents, and 2 was more potent antimicrobial agents than the parent drug as well other fluoroquinolones. Compounds 3 and 4 showed a significant activity against Fusarium solani. Moreover, these three derivatives were evaluated for inhibitory activities against enzyme urease, carbonic anhydrase II, and α-chymotrypsin. Results showed their selectivity against urease enzyme. Based on their nontoxic behavior, these derivatives may be potential agents for further studies. 相似文献
55.
Ustun Yilmaz Aysun Unal Semih Gul Gulay Demirtas Ayca Inci Yasin Sahinturk 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2022,26(1):191-196
This prospective study compared methods using both arterial and venous needles with back eyes with those using only arterial needle with back eye for arteriovenous fistula cannulation. Sixty-one patients receiving hemodialysis (HD) via an arteriovenous fistula were evaluated. All patients underwent arteriovenous fistula puncture using only arterial needle with back eye in first 3 months and both arterial and venous needles with back eyes in following 3 months. Arterial and venous pressures, blood flow velocities, total blood volume cleared, and Kt/V values were compared. Mean blood flow velocity, arterial pressure, Kt/V, and cleared total blood volume values were higher and venous pressure was lower in patients who underwent cannulation using both needles with back eyes than in those with only the arterial needle with back eye. For arteriovenous fistula cannulation, using both arterial and venous needles with back eyes provides adequate HD more successfully. 相似文献
56.
Yucel Erbilgin Ozden Hatirnaz Ng Ismail Can Sinem Firtina Fulya Kucukcankurt Serap Karaman Zeynep Karakas Tulin Tiraje Celkan Emine Zengin Sema Aylan Gelen Gul Nihal Ozdemir Yildiz Yildirmak Omer Dogru Turkan Tansel Khusan Khodzhaev Ozlem Toluk Ugur Ozbek Muge Sayitoglu 《International journal of laboratory hematology》2021,43(5):1093-1103
57.
58.
Orsolya Balogh Valentin Brodszky László Gulácsi Emese Herédi Krisztina Herszényi Hajnalka Jókai Sarolta Kárpáti Petra Baji Éva Remenyik Andrea Szegedi Péter Holló 《The European journal of health economics》2014,15(1):101-109
Background
Despite the widespread availability of biological drugs in psoriasis, there is a shortage of disease burden studies.Objectives
To assess the cost-of-illness and quality of life of patients with moderate to severe psoriasis in Hungary.Methods
Consecutive patients with Psoriasis Area and Severity Index (PASI) > 10 and Dermatology Life Quality Index (DLQI) > 10, or treated with traditional systemic (TST) or biological systemic treatment (BST) were included. Demographic data, clinical characteristics, psoriasis related medication, health care utilizations and employment status in the previous 12 months were recorded. Costing was performed from the societal perspective applying the human capital approach. Quality of life was assessed using DLQI and EQ-5D measures.Results
Two-hundred patients were involved (females 32 %) with a mean age of 51 (SD 13) years, 103 (52 %) patients were on BST. Mean PASI, DLQI and EQ-5D scores were 8 (SD 10), 6 (SD 7) and 0.69 (SD 0.3), respectively. The mean total cost was €9,254/patient/year (SD 8,502) with direct costs accounting for 86 %. The main cost driver was BST (mean €7,339/patient/year). Total costs differed significantly across treatment subgroups, mean (SD): no systemic therapy €2,186 (4,165), TST €2,388 (4,106) and BST €15,790 (6,016) (p < 0,001). Patients with BST had better PASI and DLQI scores (p < 0.01) than the other two subgroups.Conclusions
Patients with biological treatment have a significantly better quality of life and higher total costs than patients with or without traditional systemic treatment. Our study is the largest in Europe and the first in the CEE region that provides cost-of-illness data in psoriasis involving patients with BST.59.
Fatih Taskesen Zulfu Arikanoglu Omer Uslukaya Abdullah Oguz Ibrahim Aliosmanoglu Abdurrahim Dusak Gul Turkcu Hekim Kuzu 《International surgery》2014,99(5):595-599
Xanthogranulomatous cholecystitis is a rare variant of chronic cholecystitis characterized by severe proliferative fibrosis and accumulation of lipid-laden macrophages in regions of destructive inflammation. Xanthogranulomatous cholecystitis clinically and radiologically mimics early-stage gallbladder cancer, with wall thickening on computed tomography. The study included 14 xanthogranulomatous cholecystitis patients that were identified following retrospective analysis of the records of 1248 patients that underwent cholecystectomy between 2005 and 2011. Mean age of the 5 male and 9 female patients was 56.7 years. All 14 patients had gallbladder stones; 10 had a history of acute cholecystitis, 1 had cholangitis, and 2 presented with obstructive jaundice. A right-upper quadrant mass was palpable in 2 patients. All patients underwent cholecystectomy. Open surgery was planned and performed in 6 of the 14 patients, and laparoscopic cholecystectomy was planned in 8 patients, but was converted to open surgery in 1 case. In total, 1 patient developed wound infection, 1 patient had postoperative pneumonia, and 1 patient developed intraabdominal hematoma. None of the patients in the series died. Xanthogranulomatous cholecystitis is difficult to diagnose, both preoperatively and intraoperatively, and definitive diagnosis depends exclusively on pathological examination. Xanthogranulomatous cholecystitis should be a consideration in all difficult cholecystectomy cases. 相似文献
60.